Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.
Ono K, Iwasaki YK, Akao M, Ikeda T, Ishii K, Inden Y, Kusano K, Kobayashi Y, Koretsune Y, Sasano T, Sumitomo N, Takahashi N, Niwano S, Hagiwara N, Hisatome I, Furukawa T, Honjo H, Maruyama T, Murakawa Y, Yasaka M, Watanabe E, Aiba T, Amino M, Itoh H, Ogawa H, Okumura Y, Aoki-Kamiya C, Kishihara J, Kodani E, Komatsu T, Sakamoto Y, Satomi K, Shiga T, Shinohara T, Suzuki A, Suzuki S, Sekiguchi Y, Nagase S, Hayami N, Harada M, Fujino T, Makiyama T, Maruyama M, Miake J, Muraji S, Murata H, Morita N, Yokoshiki H, Yoshioka K, Yodogawa K, Inoue H, Okumura K, Kimura T, Tsutsui H, Shimizu W; Japanese Circulation Society and Japanese Heart Rhythm Society Joint Working Group. Ono K, et al. Among authors: koretsune y. Circ J. 2022 Oct 25;86(11):1790-1924. doi: 10.1253/circj.CJ-20-1212. Epub 2022 Mar 11. Circ J. 2022. PMID: 35283400 Free article. No abstract available.
Investigation of the optimal treatment strategy for atrial fibrillation in Japan.
Yamashita T, Ogawa S, Aizawa Y, Atarashi H, Inoue H, Ohe T, Okumura K, Kato T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Nakaya H, Nakayama T, Hirai M, Fukatani M, Mitamura H, Yamazaki T; J-RHYTHM Investigators. Yamashita T, et al. Among authors: koretsune y. Circ J. 2003 Sep;67(9):738-41. doi: 10.1253/circj.67.738. Circ J. 2003. PMID: 12939546 Free article. Clinical Trial.
Randomized study of angiotensin II type 1 receptor blocker vs dihydropiridine calcium antagonist for the treatment of paroxysmal atrial fibrillation in patients with hypertension.
Yamashita T, Ogawa S, Aizawa Y, Atarashi H, Inoue H, Ohe T, Okumura K, Ohtsu H, Kato T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Nakaya H, Hirai M, Hirayama A, Fukatani M, Mitamura H, Yamazaki T, Watanabe E; J-RHYTHM II Investigators. Yamashita T, et al. Among authors: koretsune y. Circ J. 2006 Oct;70(10):1318-21. doi: 10.1253/circj.70.1318. Circ J. 2006. PMID: 16998266 Free article. Clinical Trial.
Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study.
Ogawa S, Yamashita T, Yamazaki T, Aizawa Y, Atarashi H, Inoue H, Ohe T, Ohtsu H, Okumura K, Katoh T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Tabuchi T, Nakaya H, Nakayama T, Hirai M, Fukatani M, Mitamura H; J-RHYTHM Investigators. Ogawa S, et al. Among authors: koretsune y. Circ J. 2009 Feb;73(2):242-8. doi: 10.1253/circj.cj-08-0608. Epub 2008 Dec 8. Circ J. 2009. PMID: 19060419 Free article. Clinical Trial.
Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled,double-blind study (J-BAF Study).
Yamashita T, Ogawa S, Sato T, Aizawa Y, Atarashi H, Fujiki A, Inoue H, Ito M, Katoh T, Kobayashi Y, Koretsune Y, Kumagai K, Niwano S, Okazaki O, Okumura K, Saku K, Tanabe T, Origasa H; J-BAF Investigators. Yamashita T, et al. Among authors: koretsune y. Circ J. 2009 Jun;73(6):1020-7. doi: 10.1253/circj.cj-08-1061. Epub 2009 Apr 9. Circ J. 2009. PMID: 19359813 Free article. Clinical Trial.
Sex-related differences in the risk factor profile and medications of patients with atrial fibrillation recruited in J-TRACE.
Inoue H, Nozawa T, Hirai T, Goto S, Origasa H, Shimada K, Uchiyama S, Hirabayashi T, Koretsune Y, Ono S, Hasegawa T, Sasagawa Y, Kaneko Y, Ikeda Y; J-TRACE Investigators. Inoue H, et al. Among authors: koretsune y. Circ J. 2010 Apr;74(4):650-4. doi: 10.1253/circj.cj-09-0802. Epub 2010 Feb 20. Circ J. 2010. PMID: 20173301 Free article.
Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: results of the J-RHYTHM Registry.
Inoue H, Okumura K, Atarashi H, Yamashita T, Origasa H, Kumagai N, Sakurai M, Kawamura Y, Kubota I, Matsumoto K, Kaneko Y, Ogawa S, Aizawa Y, Chinushi M, Kodama I, Watanabe E, Koretsune Y, Okuyama Y, Shimizu A, Igawa O, Bando S, Fukatani M, Saikawa T, Chishaki A; J-RHYTHM Registry Investigators. Inoue H, et al. Among authors: koretsune y. Circ J. 2013;77(9):2264-70. doi: 10.1253/circj.cj-13-0290. Epub 2013 May 25. Circ J. 2013. PMID: 23708863 Free article. Clinical Trial.
CHADS2 and CHA2DS2-VASc scores as bleeding risk indices for patients with atrial fibrillation: the Bleeding with Antithrombotic Therapy Study.
Toyoda K, Yasaka M, Uchiyama S, Iwade K, Koretsune Y, Nagata K, Sakamoto T, Nagao T, Yamamoto M, Gotoh J, Takahashi JC, Minematsu K; Bleeding with Antithrombotic Therapy Study Group. Toyoda K, et al. Among authors: koretsune y. Hypertens Res. 2014 May;37(5):463-6. doi: 10.1038/hr.2013.150. Epub 2013 Nov 7. Hypertens Res. 2014. PMID: 24196199
281 results